Impact of cardiac sarcoidosis on admissions for acute-on-chronic combined systolic and diastolic heart failure

13 May 2024 (09:00 - 09:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Gabriel Yeap

(United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail

Sex and gender differences in characteristics, treatment, and short-term prognosis among patients with acute myocarditis in Korea

Doctor M. Kim (Seoul, KR)

Abstract Slides

Presentation thumbnail

The early evaluation of diuretic resistance as recommended by ESC Guidelines predicts long-term outcomes in patients with acute heart failure.

Mr J. Lopez Azor (Majadahonda, ES)

Abstract Slides Video

Presentation thumbnail

A multi-centre audit on the impact of optimal guideline directed medical therapy (GDMT) on left ventricular ejection fraction (LVEF) in Irish heart failure nurse-led clinics.

Ms J. Aherne (Cork, IE)

Abstract Slides Video

Presentation thumbnail

Congestion as a crucial factor determining albuminuria in in patients with cardiorenal disease

Doctor P. Llacer (Madrid, ES)

Abstract Slides Video

Presentation thumbnail

The association between body mass index and right ventricular dysfunction in orthopedic trauma

Associate Professor H. Kim (Guri, KR)

Abstract Slides Video

Access the full session

Session thumbnail

Acute heart failure - clinical 1

The Event

Event poster

Heart Failure 2024

13 May 2024 09:00 CET

You may be interested in

Congress Presentation

Heart failure as a frequent bystander in sarcoidosis - characterization of sarcoidosis patients with and without heart failure.

Congress Presentation

Sarcoidosis and heart failure

Congress Presentation

Prevalence of cardiovascular complications and factors associated with higher case-fatality rate among hospitalized patients with sarcoidosis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources